These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 32256490)

  • 1. Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease.
    Caër C; Wick MJ
    Front Immunol; 2020; 11():410. PubMed ID: 32256490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD.
    Liu H; Dasgupta S; Fu Y; Bailey B; Roy C; Lightcap E; Faustin B
    BMC Immunol; 2019 Nov; 20(1):42. PubMed ID: 31718550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity and functions of intestinal mononuclear phagocytes.
    Joeris T; Müller-Luda K; Agace WW; Mowat AM
    Mucosal Immunol; 2017 Jul; 10(4):845-864. PubMed ID: 28378807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!
    Pantazi E; Powell N
    Front Immunol; 2019; 10():676. PubMed ID: 31024537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn's Disease Patients.
    Caër C; Gorreja F; Forsskåhl SK; Brynjolfsson SF; Szeponik L; Magnusson MK; Börjesson LG; Block M; Bexe-Lindskog E; Wick MJ
    J Crohns Colitis; 2021 Aug; 15(8):1346-1361. PubMed ID: 33537747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of gastrointestinal macrophages/phagocytes in dogs with inflammatory bowel disease (IBD) and non-IBD dogs.
    Wagner A; Junginger J; Lemensieck F; Hewicker-Trautwein M
    Vet Immunol Immunopathol; 2018 Mar; 197():49-57. PubMed ID: 29475506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive immunobiology review of IBD: With a specific glance to Th22 lymphocytes development, biology, function, and role in IBD.
    Lv J; Ibrahim YS; Yumashev A; Hjazi A; Faraz A; Alnajar MJ; Qasim MT; Ghildiyal P; Hussein Zwamel A; Fakri Mustafa Y
    Int Immunopharmacol; 2024 Aug; 137():112486. PubMed ID: 38901239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease.
    Kmieć Z; Cyman M; Ślebioda TJ
    Adv Med Sci; 2017 Mar; 62(1):1-16. PubMed ID: 28126697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.
    El-Salhy M; Solomon T; Hausken T; Gilja OH; Hatlebakk JG
    World J Gastroenterol; 2017 Jul; 23(28):5068-5085. PubMed ID: 28811704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms.
    Dignass AU; Baumgart DC; Sturm A
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():9-17. PubMed ID: 15352888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal dendritic cell and macrophage subsets: Tipping the balance to Crohn's disease?
    Magnusson MK; Wick MJ
    Eur J Microbiol Immunol (Bp); 2011 Mar; 1(1):19-24. PubMed ID: 24466433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?
    Fantini MC; Monteleone G
    Inflamm Bowel Dis; 2017 Oct; 23(10):1682-1688. PubMed ID: 28906289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
    Zhou GX; Liu ZJ
    J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.